Brito Sara, Thompson Kyle, Campistol Jaume, Colomer Jaime, Hardy Steven A, He Langping, Fernández-Marmiesse Ana, Palacios Lourdes, Jou Cristina, Jiménez-Mallebrera Cecilia, Armstrong Judith, Montero Raquel, Artuch Rafael, Tischner Christin, Wenz Tina, McFarland Robert, Taylor Robert W
Serviço de Pediatria, Centro Hospitalar de Leiria, Hospital de Santo André Leiria, Portugal ; Neuromuscular Unit, Neuropaediatrics Department, Hospital Sant Joan de Déu Barcelona, Spain.
Wellcome Trust Centre for Mitochondrial Research, Institute of Neuroscience, Newcastle University Newcastle upon Tyne, UK.
Front Genet. 2015 Mar 23;6:102. doi: 10.3389/fgene.2015.00102. eCollection 2015.
Mitochondrial diseases due to deficiencies in the mitochondrial oxidative phosphorylation system (OXPHOS) can be associated with nuclear genes involved in mitochondrial translation, causing heterogeneous early onset and often fatal phenotypes.
The authors describe the clinical features and diagnostic workup of an infant who presented with an early onset severe encephalopathy, spastic-dystonic tetraparesis, failure to thrive, seizures and persistent lactic acidemia. Brain imaging revealed thinning of the corpus callosum and diffuse alteration of white matter signal. Genetic investigation confirmed two novel mutations in the GFM1 gene, encoding the mitochondrial translation elongation factor G1 (mtEFG1), resulting in combined deficiencies of OXPHOS.
The patient shares multiple clinical, laboratory and radiological similarities with the 11 reported patients with mutations involving this gene, but presents with a stable clinical course without metabolic decompensations, rather than a rapidly progressive fatal course. Defects in GFM1 gene confer high susceptibility to neurologic or hepatic dysfunction and this is, to the best of our knowledge, the first described patient who has survived beyond early childhood. Reporting of such cases is essential so as to delineate the key clinical and neuroradiological features of this disease and provide a more comprehensive view of its prognosis.
线粒体氧化磷酸化系统(OXPHOS)缺陷所致的线粒体疾病可能与参与线粒体翻译的核基因有关,导致发病早且症状多样,往往是致命的表型。
作者描述了一名婴儿的临床特征和诊断检查过程,该婴儿出现早发性严重脑病、痉挛性肌张力障碍性四肢瘫痪、发育不良、癫痫发作和持续性乳酸性血症。脑部影像学检查显示胼胝体变薄和白质信号弥漫性改变。基因检测证实了GFM1基因中的两个新突变,该基因编码线粒体翻译延伸因子G1(mtEFG1),导致OXPHOS联合缺陷。
该患者与11例报道的涉及该基因突变的患者在临床、实验室和影像学方面有多个相似之处,但临床病程稳定,无代谢失代偿,而非快速进展的致命病程。GFM1基因缺陷使患者对神经或肝功能障碍高度敏感,据我们所知,这是首例存活至幼儿期以后的患者。报告此类病例对于明确该疾病的关键临床和神经放射学特征以及提供更全面的预后观点至关重要。